325 related articles for article (PubMed ID: 26942878)
41. Anti-tumor effects of Skp2 inhibitor AAA-237 on NSCLC by arresting cell cycle at G0/G1 phase and inducing senescence.
Liu J; Zheng X; Li W; Ren L; Li S; Yang Y; Yang H; Ge B; Du G; Shi J; Wang J
Pharmacol Res; 2022 Jul; 181():106259. PubMed ID: 35577307
[TBL] [Abstract][Full Text] [Related]
42. [Correlation of Skp2 expression in gastric carcinoma to expression of P27 and PTEN].
Ma XM; Liu JH; Guo JW; Liu Y; Zuo LF
Ai Zheng; 2006 Jan; 25(1):56-61. PubMed ID: 16405750
[TBL] [Abstract][Full Text] [Related]
43. c-myc and skp2 coordinate p27 degradation, vascular smooth muscle proliferation, and neointima formation induced by the parathyroid hormone-related protein.
Sicari BM; Troxell R; Salim F; Tanwir M; Takane KK; Fiaschi-Taesch N
Endocrinology; 2012 Feb; 153(2):861-72. PubMed ID: 22210745
[TBL] [Abstract][Full Text] [Related]
44. Mutant B-RAF signaling and cyclin D1 regulate Cks1/S-phase kinase-associated protein 2-mediated degradation of p27Kip1 in human melanoma cells.
Bhatt KV; Hu R; Spofford LS; Aplin AE
Oncogene; 2007 Feb; 26(7):1056-66. PubMed ID: 16924241
[TBL] [Abstract][Full Text] [Related]
45. Role of Cks1 overexpression in oral squamous cell carcinomas: cooperation with Skp2 in promoting p27 degradation.
Kitajima S; Kudo Y; Ogawa I; Bashir T; Kitagawa M; Miyauchi M; Pagano M; Takata T
Am J Pathol; 2004 Dec; 165(6):2147-55. PubMed ID: 15579456
[TBL] [Abstract][Full Text] [Related]
46. miR-340 inhibits tumor cell proliferation and induces apoptosis by targeting multiple negative regulators of p27 in non-small cell lung cancer.
Fernandez S; Risolino M; Mandia N; Talotta F; Soini Y; Incoronato M; Condorelli G; Banfi S; Verde P
Oncogene; 2015 Jun; 34(25):3240-50. PubMed ID: 25151966
[TBL] [Abstract][Full Text] [Related]
47. E3 Ubiquitin Ligase HRD1 Promotes Lung Tumorigenesis by Promoting Sirtuin 2 Ubiquitination and Degradation.
Liu L; Yu L; Zeng C; Long H; Duan G; Yin G; Dai X; Lin Z
Mol Cell Biol; 2020 Mar; 40(7):. PubMed ID: 31932479
[TBL] [Abstract][Full Text] [Related]
48. [The expression of Skp2 in human non-small cell lung cancer and its correlation with expression of p27 protein.].
Hu X; Liu F; Jiang B; Wang Y
Zhongguo Fei Ai Za Zhi; 2008 Aug; 11(4):547-50. PubMed ID: 20735967
[TBL] [Abstract][Full Text] [Related]
49. p27-Associated G1 arrest induced by hinokitiol in human malignant melanoma cells is mediated via down-regulation of pRb, Skp2 ubiquitin ligase, and impairment of Cdk2 function.
Liu S; Yamauchi H
Cancer Lett; 2009 Dec; 286(2):240-9. PubMed ID: 19631451
[TBL] [Abstract][Full Text] [Related]
50. Overexpression of the S-phase kinase-associated protein 2 in thyroid cancer.
Chiappetta G; De Marco C; Quintiero A; Califano D; Gherardi S; Malanga D; Scrima M; Montero-Conde C; Cito L; Monaco M; Motti ML; Pasquinelli R; Agosti V; Robledo M; Fusco A; Viglietto G
Endocr Relat Cancer; 2007 Jun; 14(2):405-20. PubMed ID: 17639054
[TBL] [Abstract][Full Text] [Related]
51. Regulation of the cell cycle inhibitor p27 and its ubiquitin ligase Skp2 in differentiation of human embryonic stem cells.
Egozi D; Shapira M; Paor G; Ben-Izhak O; Skorecki K; Hershko DD
FASEB J; 2007 Sep; 21(11):2807-17. PubMed ID: 17475922
[TBL] [Abstract][Full Text] [Related]
52. Oncogenic Ras blocks transforming growth factor-beta-induced cell-cycle arrest by degradation of p27 through a MEK/Erk/SKP2-dependent pathway.
Schepers H; Wierenga AT; Eggen BJ; Vellenga E
Exp Hematol; 2005 Jul; 33(7):747-57. PubMed ID: 15963850
[TBL] [Abstract][Full Text] [Related]
53. Bortezomib (Velcade) induces p27Kip1 expression through S-phase kinase protein 2 degradation in colorectal cancer.
Uddin S; Ahmed M; Bavi P; El-Sayed R; Al-Sanea N; AbdulJabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Hussain AR; Al-Kuraya KS
Cancer Res; 2008 May; 68(9):3379-88. PubMed ID: 18451165
[TBL] [Abstract][Full Text] [Related]
54. Skp2 gene copy number aberrations are common in non-small cell lung carcinoma, and its overexpression in tumors with ras mutation is a poor prognostic marker.
Zhu CQ; Blackhall FH; Pintilie M; Iyengar P; Liu N; Ho J; Chomiak T; Lau D; Winton T; Shepherd FA; Tsao MS
Clin Cancer Res; 2004 Mar; 10(6):1984-91. PubMed ID: 15041716
[TBL] [Abstract][Full Text] [Related]
55. Clinical and biological significance of S-phase kinase-associated protein 2 (Skp2) gene expression in gastric carcinoma: modulation of malignant phenotype by Skp2 overexpression, possibly via p27 proteolysis.
Masuda TA; Inoue H; Sonoda H; Mine S; Yoshikawa Y; Nakayama K; Nakayama K; Mori M
Cancer Res; 2002 Jul; 62(13):3819-25. PubMed ID: 12097295
[TBL] [Abstract][Full Text] [Related]
56. Dihydrotestosterone induces p27 degradation via direct binding with SKP2 in ovarian and breast cancer.
Shi P; Zhang Y; Tong X; Yang Y; Shao Z
Int J Mol Med; 2011 Jul; 28(1):109-14. PubMed ID: 21503567
[TBL] [Abstract][Full Text] [Related]
57. Knockdown of Skp2 by siRNA inhibits melanoma cell growth in vitro and in vivo.
Katagiri Y; Hozumi Y; Kondo S
J Dermatol Sci; 2006 Jun; 42(3):215-24. PubMed ID: 16504485
[TBL] [Abstract][Full Text] [Related]
58. CKS1B overexpression implicates clinical aggressiveness of hepatocellular carcinomas but not p27(Kip1) protein turnover: an independent prognosticator with potential p27 (Kip1)-independent oncogenic attributes?
Huang CW; Lin CY; Huang HY; Liu HW; Chen YJ; Shih DF; Chen HY; Juan CC; Ker CG; Huang CY; Li CF; Shiue YL
Ann Surg Oncol; 2010 Mar; 17(3):907-22. PubMed ID: 19866239
[TBL] [Abstract][Full Text] [Related]
59. p27T187A knockin identifies Skp2/Cks1 pocket inhibitors for advanced prostate cancer.
Zhao H; Lu Z; Bauzon F; Fu H; Cui J; Locker J; Zhu L
Oncogene; 2017 Jan; 36(1):60-70. PubMed ID: 27181203
[TBL] [Abstract][Full Text] [Related]
60. Inverse correlation between expression levels of p27 and the ubiquitin ligase subunit Skp2 in early esophageal squamous cell carcinoma.
Fukuchi M; Masuda N; Nakajima M; Fukai Y; Miyazaki T; Kato H; Kuwano H
Anticancer Res; 2004; 24(2B):777-83. PubMed ID: 15161026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
